June 20-24: Who said What in Biotech and Pharmaceutical Industries?


These are some fresh promises that researchers and scientists made regarding their innovation and research and the collaborators filled us with the hope to take their business to a higher level and benefit the human race;

Quote 1.

Today patients undergoing anti-HIV treatment have to take a lot of drugs every day. Our preparations will meet the expectations of Russian patients and will solve this problem”-Who said it? Answer is here

Quote 2.

While the application of new gene editing technologies in this field has great potential to improve human health, it is not without concernsWho said it? Answer is here

Quote 3.

We are seeing a strong potential in studying this bacteria for medicine, as it could be linked to the deadly pneumonias and with the development of the oncological condition itself. We should remember that this is a spore-forming bacteria, which is not susceptible to antibiotics”Who said it? Answer is here

Quote 4.

We hope our new study will provide insights into Moyamoya disease that then feed back into our work in cancer biology”Who said it? Answer is here

Quote 5.

We have been impressed by the progress that F2G has made to date and are pleased to support its next phase of growth”Who said it? Answer is here

Quote 6.

“This means it is significantly less invasive than other cardiac support systems, which work by implanting valves or screw pumps inside the ventricle”Who said it? Answer is here

Quote 7.

We are proud to have attained the approval to initiate the first Zika vaccine study in human volunteers. As of May 2016, 58 countries and territories reported continuing mosquito-borne transmission of the Zika virus; the incidences of viral infection and medical conditions caused by the virus are expanding, not contracting. We plan to dose our first subjects in the next weeks and expect to report phase I interim results later this year”-Who said it? Answer is here

Quote 8.

These findings support the long-term control of convulsive seizures by low-dose fenfluramine, while being well tolerated in this cohort of patients with Dravet syndrome”Who said it? Answer is here

Quote 9.

We are very pleased that the FDA has awarded Fast Track Designation for TK216 in Ewing sarcoma patients who have failed standard of care therapy. This rare bone cancer strikes children and young adults and there are few treatment alternatives, so it is imperative that we rapidly advance new therapeutics that have the potential to extend the lives of these patients. We look forward to beginning enrollment and dosing of Ewing sarcoma patients shortly in our phase 1 trial of TK216Who said it? Answer is here

Quote 10.

Precision Medicine is about to revolutionize how diagnostic and biological data is used to pinpoint and deliver care that is preventive, targeted and effectiveWho said it? Answer is here



Leave a reply

Your email address will not be published. Required fields are marked *